Back to top

Image: Bigstock

Axcella Health (AXLA) Looks Good: Stock Adds 5.9% in Session

Read MoreHide Full Article

Axcella Health Inc. (AXLA - Free Report) was a big mover last session, as the company saw its shares rises more than 5% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $4.2 –$5.11 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Axcella Health. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Axcella Health currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Axcella Health Inc. Price

Other top-ranked stock in the Medical - Biomedical and Genetics industry is 89BIO INC (ETNB - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>
 


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Axcella Health Inc. (AXLA) - free report >>

89BIO INC (ETNB) - free report >>